Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,056 results that match your search.22,056 results
  • On December 14 2006, the Court of First Instance (CFI) upheld that Community trade mark applications representing deer heads with the word "Venado" were confusingly similar to earlier trade marks consisting of a deer's head with a cross surrounded by a halo and the word "Jägermeister".
  • The Patent Appeal Board in Canada recently issued its decision following a hearing at which we challenged the decision of an examiner regarding inter alia the patentability of subject matter. The claims were directed to a system for trading diamonds from remote computer terminals in communication with a host computer, including the use of data structures for presenting diamond characteristics in an orderly and structured manner. The examiner's rejection reflected a trend in Canada of examiners rejecting claims to less than fully tangible inventions, or to what can be loosely called business methods.
  • The Supreme Court of the Czech Republic has considered an appeal against decisions of courts of lower instances in the case of the infringement of trade mark rights (8Tdo239/2004).
  • Acacia Technologies: an aggressive patent troll that feeds off the litigation fears of large corporations, or the champion of small technology companies who might not know how to go about enforcing their patents? Shahnaz Mahmud weighs up the evidence
  • Manufacturers of medicinal products are legally obliged to obtain regulatory approval for their product before marketing of that product may begin. However, where different salts, esters, ethers, isomers, complexes or derivatives of a brand (on-patent) drug are made by a generic company, and these differ significantly in properties with regard to safety and/or efficacy when compared to the patented drug, additional clinical data demonstrating the safety and/or efficacy of that generic drug must be submitted by the generic company to the marketing authority.
  • This month MIP publishes part one of the world's most detailed and authoritative survey of the IP market. Following five months' research, in this issue we list the leading firms in patent prosecution and contentious work in 65 jurisdictions
  • For brand managers looking to increase their product's profile and producers wanting to find new ways to finance movies and TV shows, product placement could be a win-win solution, says Brinsley Dresden, as he outlines negotiating tactics to help IP owners strike the deal they want
  • The continuing growth and popularity of the internet has created a wealth of new opportunities for trade mark owners seeking to market their goods or services online. The reliance of internet users on search engines to locate providers of particular products has led to an explosion in search engine advertising in recent years.
  • Australia PATENT PROSECUTION Tier 1 Davies Collison Cave Griffith Hack Phillips Ormonde & Fitzpatrick Spruson & Ferguson Tier 2 F B Rice & Co Shelston IP Watermark Tier 3 Blake Dawson Waldron Freehills Madderns Wray & Associates Tier 4 Allens Arthur Robinson Callinan Lawrie Cullen & Co Halford & Co Mallesons Stephen Jacques Pizzeys